Nalaganje...
AB030. Evolution of phosphodiesterase type 5 inhibitors
After launching of sildenafil citrate, the last invention of 20(th) century, in 1998, oral phosphodiesterase type 5 (PDE5) inhibitor has been established as first line treatment of erectile dysfunction and shift new paradigm of diagnosis and treatment of erectile dysfunction. The big success of sild...
Shranjeno v:
| izdano v: | Transl Androl Urol |
|---|---|
| Glavni avtor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AME Publishing Company
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4842502/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tau.2016.s030 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|